Iakentro IVF

What Iakentro IVF does

Iakentro IVF (ΜΙΥΑ Ιακέντρο) is a Greek assisted reproductive technology (ART) and reproductive genetics clinic operating dual sites in Thessaloniki and Athens. Founded in 1995 by Professor Nikolaos Prapas and Professor Ioannis Prapas — both faculty at the Aristotle University of Thessaloniki — the center delivers a full ART service portfolio including IVF, ICSI, IMSI, IUI, IVM, vitrification, preimplantation genetic screening/diagnosis (PGS/PGD), ENDOTEST, FISH, sperm DNA fragmentation analysis, ovarian tissue cryopreservation and transplantation, surrogacy coordination, and gamete donation programs. It complements these core procedures with non-invasive prenatal testing via PrenatalSafe® Karyo and a 9-language patient interface supporting medical-tourism demand from the Balkans, Italy, and Eastern Europe. Quality systems are formalized under ISO 9001:2015 and BV Certification EN 15224, and the clinical team holds PhD and master-level credentials in embryology, genetics, and molecular biology, with a peer-reviewed publication record in embryo-uterine medicine and ovarian cryopreservation.

The business model is per-procedure/per-cycle fee-for-service billing to self-paying patients, with cross-border patient acquisition supported by multilingual case management and international partnerships (e.g., Med-Professionals, Raprui Center in Italy). The center is founder-owned (no external funding rounds), privately held, and operates with an 11–50 employee headcount. The cryopreservation bank has been transferred to ASSISTING NATURE AE to preserve continuity for cryostored material, and the company has announced cessation of IAKENTRO operations effective July 31, 2026, indicating a wind-down rather than an ongoing operating business.

Name

Iakentro IVF

Legal name

IAKENTRO

Website

https://iakentro.com

Company type

Private

Founded year

1995

Operating status

Closed

Headcount range

11–50 employees

Short description

Iakentro IVF is a Greek assisted reproductive technology and reproductive genetics clinic with sites in Thessaloniki and Athens, founded in 1995 by the Prapas brothers, serving domestic and international fertility patients through IVF, PGT, and genetic services.

Ownership category

akta.pro rank

Product category

Fertility and Reproductive Medicine Services

NAICS

Other Ambulatory Health Care Services (6219), Medical and Diagnostic Laboratories (62151)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

akta.pro secondary industries

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)

Keywords

• IVF fertility treatments
• Assisted reproduction services
• Reproductive medicine
• Cryopreservation services
• Preimplantation genetic testing

Headquarters

HQ city

Thessaloníki

HQ country

Greece

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. IVF and Fertility Treatment Services: Medical services revenue from assisted reproduction treatments including IVF, ICSI, egg donation, sperm donation, embryo donation, surrogacy, and fertility preservation. Revenue generated through direct patient payments and insurance coverage through EOPPY (Greek national health system).

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Iakentro IVF is a medical center that provides comprehensive assisted reproduction and fertility services, including in vitro fertilization (IVF), ICSI, IUI, IVM, preimplantation genetic screening/diagnosis, and cryopreservation of gametes, embryos, and reproductive tissue. The clinic also runs sperm, egg, and embryo donation programs, surrogacy arrangements, fertility preservation for cancer patients, and diagnostic laboratory testing (ENDOTEST, FISH, DNA fragmentation). Services are delivered through physical clinic locations in Thessaloniki and Athens with in-house embryology, andrology, endocrinology, genetics, and molecular biology laboratories.

Product overview

Iakentro IVF is a comprehensive assisted reproduction center offering a full spectrum of fertility treatments and diagnostic services. The core offering includes IVF, ICSI, IUI, and IVM procedures, complemented by advanced embryology laboratory techniques (IMSI, Assisted Hatching, FISH, DNA Fragmentation, ENDOTEST). The center provides comprehensive cryopreservation services via vitrification for eggs, sperm, embryos, ovarian tissue, and testicular tissue. Donation programs include sperm, egg, and embryo donation, alongside surrogacy services. Genetic testing capabilities encompass Preimplantation Genetic Screening (PGS) and Diagnosis (PGD), plus the PrenatalSafe® Karyo non-invasive prenatal test. Surgical services include laparoscopy and hysteroscopy, with specialized offerings such as ovarian transplantation for cancer survivors. The center operates departments in Embryology, Andrology, Endocrinology, and Genetics-Molecular Biology, with facilities in Thessaloniki and Athens.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) The primary assisted reproduction technique offered, involving egg retrieval, fertilization in laboratory conditions, and embryo transfer. For couples and individuals seeking fertility treatment.
• ICSI (Intracytoplasmic Sperm Injection) Microfertilization technique where a single sperm is injected directly into an egg. For couples facing male factor infertility.
• IUI (Intrauterine Insemination) Artificial insemination technique placing processed sperm directly into the uterine cavity. For couples requiring less invasive fertility treatment.
• IVM (In Vitro Maturation) Laboratory maturation of immature eggs retrieved from follicles. For patients needing alternatives to standard IVF hormonal stimulation.
• Egg Donation Program Donor oocyte program for women unable to use their own eggs, including those with premature ovarian failure or advanced reproductive age.
• Sperm Donation Program Donor sperm program for couples requiring donor sperm for assisted reproduction and for single women seeking pregnancy.
• Embryo Donation Program Donated embryo program for couples requiring donated embryos to achieve pregnancy.
• Surrogacy Program Surrogacy arrangements for couples unable to carry a pregnancy themselves.
• Vitrification Cryopreservation Advanced cryopreservation method for gametes and embryos using flash-freezing technique with high survival rates.
• Egg Freezing (Oocyte Cryopreservation) Cryopreservation of eggs for future use in assisted reproduction. For women seeking fertility preservation.
• Sperm Freezing Cryopreservation of sperm for future use in assisted reproduction.
• Embryo Freezing Cryopreservation of embryos for future use.
• Ovarian Tissue Freezing Cryopreservation of ovarian cortical tissue containing primordial follicles for future transplantation, particularly for cancer patients.
• Testicular Tissue Freezing

Quantifiable outcome

• Successful homologous ovarian transplantation performed in February 2017, with patient showing first ovulation and hormone levels returning to reproductive age normal levels
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered minor.

• ASSISTING NATURE AEminorOthers · 31 July 2026Cryobank partnership for transferring and storing cryopreserved biological materials. Iakentro's cryopreservation bank will be transferred to ASSISTING NATURE AE facilities in Pylaia (G. Kranidioti St. 2) upon Iakentro's closure on July 31, 2026. Patients can contact ASSISTING NATURE AE at 2310424294 after the transition.
• Med-Professionals Medical Communication GroupminorGTM or Marketing Partner · 1 January 2022Medical communication agency representing Iakentro at the Greek Tourism Workshop 2022 in Qatar, supporting medical tourism development and high-income visitor attraction.
• Raprui CenterminorStrategic or Co-development Partner · 1 January 2018Italian fertility center collaboration. Iakentro and Raprui co-presented at the SIERR (Italian Society of Clinical Embryologists) annual congress in Rome, sharing expertise in assisted reproduction techniques.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Instituto Bernabeu: Spain-based fertility clinic offering IVF, genetic testing, and egg donation with a strong international patient program. Comparable as a Southern European ART specialist targeting medical tourism patients in similar source markets.
• IVI-RMA Global (Eugin Group): One of the world's largest IVF clinic networks operating across Europe, including Spain. Directly comparable as a multi-country ART provider with strong medical tourism positioning and similar service breadth (IVF, ICSI, PGD, egg donation, fertility preservation).
• CREATE Fertility: UK fertility clinic group focused on mild/more natural IVF cycles and advanced ART techniques. Comparable as an ART specialist serving international patients with similar technology orientation (IMSI, advanced embryo selection).
• Newlife IVF Greece: Greek fertility clinic offering comprehensive IVF, ICSI, PGD/PGS, and egg donation services with strong medical tourism positioning. Directly comparable specialty, geography, and target patient base to IAKENTRO.
• Assisting Nature (Assisting Nature IVF Center): Greek IVF clinic headquartered in Thessaloniki offering IVF, ICSI, egg donation, and cryopreservation. Directly comparable as a domestic ART competitor and the named successor for IAKENTRO's cryobank transfers upon closure.
• Institute of Life - IASO: Athens-based fertility center within the IASO hospital group, providing IVF, PGD/PGS, and fertility preservation. Comparable as a Greek ART provider with overlapping metropolitan and international patient segments.
• Embryolab: Thessaloniki-based IVF clinic and embryology lab offering ART services, fertility preservation, and donor programs. Comparable as a same-city, same-specialty competitor with overlapping international patient base.

Broad incumbents

• Virtus Health: Australia-listed operator of fertility clinics across Australia, Ireland, UK, and Singapore. Comparable as a larger, multi-country ART provider with similar service mix but at materially greater scale and public-market visibility.
• Monash IVF: Australia-listed fertility services group with clinics across Australia and Southeast Asia. Comparable as an established, multi-site ART provider with full-service reproductive medicine offerings, though at far greater scale.

Others

• Genea Biomedx: ART technology and medical device company supplying fertility clinics with culture media, time-lapse incubators, and lab instrumentation. Adjacent as an enabling vendor to ART clinics like IAKENTRO rather than a direct competitor.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/iakentroivf
• YouTubeyoutube.com/channel/iakentro
• Facebookfacebook.com/iakentroivf
• LinkedInlinkedin.com/company/iakentro

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iakentro IVF